{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T09:34:01Z","timestamp":1782552841191,"version":"3.54.5"},"reference-count":10,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T00:00:00Z","timestamp":1709510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100001946","name":"American Skin Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001946","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jaadcasereports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JAAD Case Reports"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jdcr.2024.02.022","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T17:40:53Z","timestamp":1709746853000},"page":"1-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream"],"prefix":"10.1016","volume":"47","author":[{"given":"Sophia S.","family":"Tran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin","family":"Ungar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M.","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdcr.2024.02.022_bib1","series-title":"Perioral Dermatitis","author":"Tolaymat","year":"2023"},{"issue":"3","key":"10.1016\/j.jdcr.2024.02.022_bib2","doi-asserted-by":"crossref","first-page":"386","DOI":"10.5021\/ad.2011.23.3.386","article-title":"Childhood granulomatous periorificial dermatitis","volume":"23","author":"Kim","year":"2011","journal-title":"Ann Dermatol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.02.022_bib3","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/jdv.17817","article-title":"Pharmacological interventions for periorificial (perioral) dermatitis in children and adults: a systematic review","volume":"36","author":"Gray","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"3","key":"10.1016\/j.jdcr.2024.02.022_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5070\/D30731Q371","article-title":"Case report: fluocinonide-induced perioral dermatitis in a patient with psoriasis","volume":"15","author":"Kosari","year":"2009","journal-title":"Dermatol Online J"},{"issue":"1","key":"10.1016\/j.jdcr.2024.02.022_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2005.01.010","article-title":"Adverse effects of topical glucocorticosteroids","volume":"54","author":"Hengge","year":"2006","journal-title":"J Am Acad Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.02.022_bib6","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jaad.2008.03.043","article-title":"A randomized, double-blind, vehicle-controlled study of 1% pimecrolimus cream in adult patients with perioral dermatitis","volume":"59","author":"Schwarz","year":"2008","journal-title":"J Am Acad Dermatol"},{"issue":"8","key":"10.1016\/j.jdcr.2024.02.022_bib7","first-page":"20","volume":"4","author":"Rosso","year":"2011","journal-title":"J Clin Aesthet Dermatol"},{"issue":"1","key":"10.1016\/j.jdcr.2024.02.022_bib8","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s40257-022-00748-2","article-title":"Ruxolitinib cream 1.5%: a review in mild to moderate atopic dermatitis","volume":"24","author":"Hoy","year":"2023","journal-title":"Am J Clin Dermatol"},{"issue":"16","key":"10.1016\/j.jdcr.2024.02.022_bib9","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMoa2118828","article-title":"Two phase 3, randomized, controlled trials of ruxolitinib cream for vitiligo","volume":"387","author":"Rosmarin","year":"2022","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jdcr.2024.02.022_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.36849\/JDD.7268","article-title":"A review on the use of topical ruxolitinib for the treatment of vitiligo","volume":"22","author":"Grossmann","year":"2023","journal-title":"J Drugs Dermatol"}],"container-title":["JAAD Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352512624000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,16]],"date-time":"2024-05-16T04:05:31Z","timestamp":1715832331000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352512624000821"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":10,"alternative-id":["S2352512624000821"],"URL":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.02.022","relation":{},"ISSN":["2352-5126"],"issn-type":[{"value":"2352-5126","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of granulomatous perioral dermatitis with 1.5% topical ruxolitinib cream","name":"articletitle","label":"Article Title"},{"value":"JAAD Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdcr.2024.02.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}